nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—RRM2—Gemcitabine—pancreatic cancer	0.354	0.476	CbGbCtD
Hydroxyurea—RRM1—Gemcitabine—pancreatic cancer	0.354	0.476	CbGbCtD
Hydroxyurea—CYP2D6—Tamoxifen—pancreatic cancer	0.0158	0.0213	CbGbCtD
Hydroxyurea—CYP2D6—Erlotinib—pancreatic cancer	0.0135	0.0181	CbGbCtD
Hydroxyurea—CYP2D6—Doxorubicin—pancreatic cancer	0.00664	0.00893	CbGbCtD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00638	0.0962	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00526	0.0792	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.0032	0.0483	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00264	0.0398	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00254	0.0383	CbGpPWpGaD
Hydroxyurea—RRM2—Gefitinib—Erlotinib—pancreatic cancer	0.00235	0.588	CbGdCrCtD
Hydroxyurea—RRM1—E2F transcription factor network—RBBP8—pancreatic cancer	0.00212	0.032	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00209	0.0315	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—TYMS—pancreatic cancer	0.00203	0.0305	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RBBP8—pancreatic cancer	0.00175	0.0264	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—TYMP—pancreatic cancer	0.00161	0.0243	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.00145	0.0218	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—TYMP—pancreatic cancer	0.00133	0.02	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—DPYD—pancreatic cancer	0.00128	0.0192	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00124	0.0187	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—TYMS—pancreatic cancer	0.00119	0.018	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.00119	0.018	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—DPYD—pancreatic cancer	0.00105	0.0158	CbGpPWpGaD
Hydroxyurea—RRM1—Azacitidine—Gemcitabine—pancreatic cancer	0.00101	0.253	CbGdCrCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.0009	0.0136	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.000808	0.0122	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—TYMS—pancreatic cancer	0.000767	0.0116	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—TYMS—pancreatic cancer	0.000728	0.011	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—SYCP1—pancreatic cancer	0.000685	0.0103	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000667	0.01	CbGpPWpGaD
Hydroxyurea—RRM2—Azacitidine—Gemcitabine—pancreatic cancer	0.000635	0.159	CbGdCrCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000634	0.00955	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—PLAU—pancreatic cancer	0.000633	0.00954	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—TYMS—pancreatic cancer	0.000632	0.00952	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—TYMS—pancreatic cancer	0.000599	0.00903	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000569	0.00857	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000562	0.00846	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000549	0.00827	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—PLAU—pancreatic cancer	0.000521	0.00785	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—RB1—pancreatic cancer	0.00052	0.00784	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000491	0.0074	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000482	0.00727	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.00048	0.00724	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—TYMS—pancreatic cancer	0.000458	0.00691	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000457	0.00689	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000452	0.00681	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—RB1—pancreatic cancer	0.000428	0.00645	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000413	0.00623	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000395	0.00596	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	0.000386	0.00582	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000376	0.00567	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000374	0.00563	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000372	0.00561	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000362	0.00545	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000355	0.00536	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—RBBP8—pancreatic cancer	0.000351	0.00528	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000336	0.00506	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—RB1—pancreatic cancer	0.000311	0.00468	CbGpPWpGaD
Hydroxyurea—RRM1—E2F transcription factor network—MYC—pancreatic cancer	0.00031	0.00467	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000305	0.0046	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000276	0.00417	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PPP2R5B—pancreatic cancer	0.000273	0.00411	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000272	0.0041	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.000269	0.00406	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.000269	0.00406	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—RB1—pancreatic cancer	0.000262	0.00395	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.000258	0.00389	CbGpPWpGaD
Hydroxyurea—RRM2—E2F transcription factor network—MYC—pancreatic cancer	0.000255	0.00384	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—FOXM1—pancreatic cancer	0.000243	0.00366	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	0.00023	0.00347	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.000222	0.00334	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	0.000221	0.00333	CbGpPWpGaD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000205	0.00309	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.000198	0.00298	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	0.000195	0.00293	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PRSS1—pancreatic cancer	0.000193	0.00291	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—MYC—pancreatic cancer	0.000185	0.00279	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000184	0.00277	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	0.000182	0.00274	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.000179	0.0027	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000177	0.00267	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.000173	0.0026	CbGpPWpGaD
Hydroxyurea—Decreased appetite—Sunitinib—pancreatic cancer	0.000168	0.000904	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—ARG2—pancreatic cancer	0.000167	0.00252	CbGpPWpGaD
Hydroxyurea—Leukopenia—Fluorouracil—pancreatic cancer	0.000167	0.000899	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000167	0.000897	CcSEcCtD
Hydroxyurea—Fatigue—Sunitinib—pancreatic cancer	0.000167	0.000896	CcSEcCtD
Hydroxyurea—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000166	0.000894	CcSEcCtD
Hydroxyurea—Pain—Sunitinib—pancreatic cancer	0.000165	0.000889	CcSEcCtD
Hydroxyurea—Constipation—Sunitinib—pancreatic cancer	0.000165	0.000889	CcSEcCtD
Hydroxyurea—Discomfort—Irinotecan—pancreatic cancer	0.000164	0.000882	CcSEcCtD
Hydroxyurea—Renal failure acute—Epirubicin—pancreatic cancer	0.000164	0.00088	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000163	0.000878	CcSEcCtD
Hydroxyurea—Asthenia—Tamoxifen—pancreatic cancer	0.000162	0.000871	CcSEcCtD
Hydroxyurea—Convulsion—Fluorouracil—pancreatic cancer	0.000162	0.000871	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000161	0.000864	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.00016	0.00241	CbGpPWpGaD
Hydroxyurea—Asthenia—Erlotinib—pancreatic cancer	0.00016	0.000861	CcSEcCtD
Hydroxyurea—Discomfort—Gemcitabine—pancreatic cancer	0.00016	0.00086	CcSEcCtD
Hydroxyurea—Oedema—Irinotecan—pancreatic cancer	0.000159	0.000856	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PRSS1—pancreatic cancer	0.000159	0.00239	CbGpPWpGaD
Hydroxyurea—Infection—Irinotecan—pancreatic cancer	0.000158	0.000851	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000158	0.00085	CcSEcCtD
Hydroxyurea—Discomfort—Fluorouracil—pancreatic cancer	0.000157	0.000845	CcSEcCtD
Hydroxyurea—Nervous system disorder—Irinotecan—pancreatic cancer	0.000156	0.00084	CcSEcCtD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—MYC—pancreatic cancer	0.000156	0.00235	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000156	0.00235	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000156	0.000838	CcSEcCtD
Hydroxyurea—Haemoglobin—Docetaxel—pancreatic cancer	0.000156	0.000837	CcSEcCtD
Hydroxyurea—Hepatic failure—Doxorubicin—pancreatic cancer	0.000155	0.000836	CcSEcCtD
Hydroxyurea—Oedema—Gemcitabine—pancreatic cancer	0.000155	0.000834	CcSEcCtD
Hydroxyurea—Haemorrhage—Docetaxel—pancreatic cancer	0.000155	0.000833	CcSEcCtD
Hydroxyurea—Diarrhoea—Tamoxifen—pancreatic cancer	0.000154	0.00083	CcSEcCtD
Hydroxyurea—Infection—Gemcitabine—pancreatic cancer	0.000154	0.000829	CcSEcCtD
Hydroxyurea—Body temperature increased—Sunitinib—pancreatic cancer	0.000153	0.000822	CcSEcCtD
Hydroxyurea—Diarrhoea—Erlotinib—pancreatic cancer	0.000153	0.000822	CcSEcCtD
Hydroxyurea—Oedema—Fluorouracil—pancreatic cancer	0.000152	0.00082	CcSEcCtD
Hydroxyurea—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000152	0.000818	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000152	0.000817	CcSEcCtD
Hydroxyurea—Anorexia—Irinotecan—pancreatic cancer	0.000152	0.000816	CcSEcCtD
Hydroxyurea—Infection—Fluorouracil—pancreatic cancer	0.000151	0.000815	CcSEcCtD
Hydroxyurea—Renal failure acute—Doxorubicin—pancreatic cancer	0.000151	0.000814	CcSEcCtD
Hydroxyurea—Skin disorder—Gemcitabine—pancreatic cancer	0.000151	0.00081	CcSEcCtD
Hydroxyurea—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000149	0.000804	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000149	0.000803	CcSEcCtD
Hydroxyurea—Dizziness—Tamoxifen—pancreatic cancer	0.000149	0.000802	CcSEcCtD
Hydroxyurea—Anorexia—Gemcitabine—pancreatic cancer	0.000148	0.000795	CcSEcCtD
Hydroxyurea—Dizziness—Erlotinib—pancreatic cancer	0.000148	0.000794	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMP—pancreatic cancer	0.000146	0.0022	CbGpPWpGaD
Hydroxyurea—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000146	0.000786	CcSEcCtD
Hydroxyurea—Face oedema—Epirubicin—pancreatic cancer	0.000146	0.000784	CcSEcCtD
Hydroxyurea—Anorexia—Fluorouracil—pancreatic cancer	0.000145	0.000782	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000144	0.00216	CbGpPWpGaD
Hydroxyurea—Vomiting—Tamoxifen—pancreatic cancer	0.000143	0.000772	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000143	0.00216	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Sunitinib—pancreatic cancer	0.000142	0.000766	CcSEcCtD
Hydroxyurea—Rash—Tamoxifen—pancreatic cancer	0.000142	0.000765	CcSEcCtD
Hydroxyurea—Dermatitis—Tamoxifen—pancreatic cancer	0.000142	0.000764	CcSEcCtD
Hydroxyurea—Vomiting—Erlotinib—pancreatic cancer	0.000142	0.000763	CcSEcCtD
Hydroxyurea—Dyspnoea—Irinotecan—pancreatic cancer	0.000142	0.000763	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—TYMS—pancreatic cancer	0.000142	0.00213	CbGpPWpGaD
Hydroxyurea—Somnolence—Irinotecan—pancreatic cancer	0.000141	0.000761	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000141	0.000761	CcSEcCtD
Hydroxyurea—Headache—Tamoxifen—pancreatic cancer	0.000141	0.00076	CcSEcCtD
Hydroxyurea—Rash—Erlotinib—pancreatic cancer	0.000141	0.000757	CcSEcCtD
Hydroxyurea—Dermatitis—Erlotinib—pancreatic cancer	0.000141	0.000756	CcSEcCtD
Hydroxyurea—Angiopathy—Docetaxel—pancreatic cancer	0.000141	0.000756	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.00014	0.00212	CbGpPWpGaD
Hydroxyurea—Dyspepsia—Irinotecan—pancreatic cancer	0.00014	0.000754	CcSEcCtD
Hydroxyurea—Headache—Erlotinib—pancreatic cancer	0.00014	0.000752	CcSEcCtD
Hydroxyurea—Chills—Docetaxel—pancreatic cancer	0.000139	0.000747	CcSEcCtD
Hydroxyurea—Asthenia—Sunitinib—pancreatic cancer	0.000139	0.000746	CcSEcCtD
Hydroxyurea—Decreased appetite—Irinotecan—pancreatic cancer	0.000138	0.000744	CcSEcCtD
Hydroxyurea—Dyspnoea—Gemcitabine—pancreatic cancer	0.000138	0.000744	CcSEcCtD
Hydroxyurea—Somnolence—Gemcitabine—pancreatic cancer	0.000138	0.000741	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—ARG2—pancreatic cancer	0.000138	0.00208	CbGpPWpGaD
Hydroxyurea—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000137	0.000739	CcSEcCtD
Hydroxyurea—Fatigue—Irinotecan—pancreatic cancer	0.000137	0.000738	CcSEcCtD
Hydroxyurea—Alopecia—Docetaxel—pancreatic cancer	0.000137	0.000736	CcSEcCtD
Hydroxyurea—Breast disorder—Epirubicin—pancreatic cancer	0.000136	0.000734	CcSEcCtD
Hydroxyurea—Constipation—Irinotecan—pancreatic cancer	0.000136	0.000732	CcSEcCtD
Hydroxyurea—Pain—Irinotecan—pancreatic cancer	0.000136	0.000732	CcSEcCtD
Hydroxyurea—Dyspnoea—Fluorouracil—pancreatic cancer	0.000136	0.000731	CcSEcCtD
Hydroxyurea—Somnolence—Fluorouracil—pancreatic cancer	0.000136	0.000729	CcSEcCtD
Hydroxyurea—Face oedema—Doxorubicin—pancreatic cancer	0.000135	0.000726	CcSEcCtD
Hydroxyurea—Erythema—Docetaxel—pancreatic cancer	0.000135	0.000725	CcSEcCtD
Hydroxyurea—Decreased appetite—Gemcitabine—pancreatic cancer	0.000135	0.000725	CcSEcCtD
Hydroxyurea—Dyspepsia—Fluorouracil—pancreatic cancer	0.000134	0.000722	CcSEcCtD
Hydroxyurea—Nausea—Tamoxifen—pancreatic cancer	0.000134	0.000721	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000134	0.00072	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000134	0.00201	CbGpPWpGaD
Hydroxyurea—Fatigue—Gemcitabine—pancreatic cancer	0.000134	0.000719	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—BRCA2—pancreatic cancer	0.000133	0.00201	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000133	0.002	CbGpPWpGaD
Hydroxyurea—Constipation—Gemcitabine—pancreatic cancer	0.000133	0.000713	CcSEcCtD
Hydroxyurea—Pain—Gemcitabine—pancreatic cancer	0.000133	0.000713	CcSEcCtD
Hydroxyurea—Nausea—Erlotinib—pancreatic cancer	0.000133	0.000713	CcSEcCtD
Hydroxyurea—Decreased appetite—Fluorouracil—pancreatic cancer	0.000133	0.000713	CcSEcCtD
Hydroxyurea—Diarrhoea—Sunitinib—pancreatic cancer	0.000132	0.000711	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000132	0.000708	CcSEcCtD
Hydroxyurea—Feeling abnormal—Irinotecan—pancreatic cancer	0.000131	0.000706	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000131	0.000704	CcSEcCtD
Hydroxyurea—Pain—Fluorouracil—pancreatic cancer	0.00013	0.000701	CcSEcCtD
Hydroxyurea—Pancreatitis—Epirubicin—pancreatic cancer	0.000128	0.000688	CcSEcCtD
Hydroxyurea—Dizziness—Sunitinib—pancreatic cancer	0.000128	0.000687	CcSEcCtD
Hydroxyurea—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000128	0.000687	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TYMS—pancreatic cancer	0.000127	0.00191	CbGpPWpGaD
Hydroxyurea—Breast disorder—Doxorubicin—pancreatic cancer	0.000126	0.000679	CcSEcCtD
Hydroxyurea—Body temperature increased—Irinotecan—pancreatic cancer	0.000126	0.000677	CcSEcCtD
Hydroxyurea—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000126	0.000676	CcSEcCtD
Hydroxyurea—Anaemia—Docetaxel—pancreatic cancer	0.000125	0.00067	CcSEcCtD
Hydroxyurea—Pancytopenia—Epirubicin—pancreatic cancer	0.000124	0.000667	CcSEcCtD
Hydroxyurea—Vomiting—Sunitinib—pancreatic cancer	0.000123	0.000661	CcSEcCtD
Hydroxyurea—Body temperature increased—Gemcitabine—pancreatic cancer	0.000123	0.000659	CcSEcCtD
Hydroxyurea—Neutropenia—Epirubicin—pancreatic cancer	0.000122	0.000656	CcSEcCtD
Hydroxyurea—Dysuria—Epirubicin—pancreatic cancer	0.000122	0.000656	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000122	0.00184	CbGpPWpGaD
Hydroxyurea—Rash—Sunitinib—pancreatic cancer	0.000122	0.000655	CcSEcCtD
Hydroxyurea—Dermatitis—Sunitinib—pancreatic cancer	0.000122	0.000655	CcSEcCtD
Hydroxyurea—Headache—Sunitinib—pancreatic cancer	0.000121	0.000651	CcSEcCtD
Hydroxyurea—Leukopenia—Docetaxel—pancreatic cancer	0.000121	0.000649	CcSEcCtD
Hydroxyurea—Body temperature increased—Fluorouracil—pancreatic cancer	0.000121	0.000648	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMP—pancreatic cancer	0.00012	0.00181	CbGpPWpGaD
Hydroxyurea—Weight increased—Epirubicin—pancreatic cancer	0.000119	0.000639	CcSEcCtD
Hydroxyurea—Pancreatitis—Doxorubicin—pancreatic cancer	0.000118	0.000637	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GLP1R—pancreatic cancer	0.000118	0.00178	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000118	0.00178	CbGpPWpGaD
Hydroxyurea—Hypersensitivity—Irinotecan—pancreatic cancer	0.000117	0.000631	CcSEcCtD
Hydroxyurea—Convulsion—Docetaxel—pancreatic cancer	0.000117	0.000628	CcSEcCtD
Hydroxyurea—Drowsiness—Epirubicin—pancreatic cancer	0.000116	0.000626	CcSEcCtD
Hydroxyurea—Infestation—Epirubicin—pancreatic cancer	0.000116	0.000626	CcSEcCtD
Hydroxyurea—Infestation NOS—Epirubicin—pancreatic cancer	0.000116	0.000626	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—DPYD—pancreatic cancer	0.000116	0.00175	CbGpPWpGaD
Hydroxyurea—Nausea—Sunitinib—pancreatic cancer	0.000115	0.000617	CcSEcCtD
Hydroxyurea—Pancytopenia—Doxorubicin—pancreatic cancer	0.000115	0.000617	CcSEcCtD
Hydroxyurea—Asthenia—Irinotecan—pancreatic cancer	0.000114	0.000614	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000114	0.000614	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000114	0.000613	CcSEcCtD
Hydroxyurea—Stomatitis—Epirubicin—pancreatic cancer	0.000113	0.00061	CcSEcCtD
Hydroxyurea—Neutropenia—Doxorubicin—pancreatic cancer	0.000113	0.000607	CcSEcCtD
Hydroxyurea—Dysuria—Doxorubicin—pancreatic cancer	0.000113	0.000607	CcSEcCtD
Hydroxyurea—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000112	0.000604	CcSEcCtD
Hydroxyurea—Asthenia—Gemcitabine—pancreatic cancer	0.000111	0.000598	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—TERT—pancreatic cancer	0.00011	0.00166	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—SLC2A2—pancreatic cancer	0.00011	0.00166	CbGpPWpGaD
Hydroxyurea—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00011	0.000592	CcSEcCtD
Hydroxyurea—Oedema—Docetaxel—pancreatic cancer	0.00011	0.000592	CcSEcCtD
Hydroxyurea—Weight increased—Doxorubicin—pancreatic cancer	0.00011	0.000591	CcSEcCtD
Hydroxyurea—Infection—Docetaxel—pancreatic cancer	0.000109	0.000588	CcSEcCtD
Hydroxyurea—Diarrhoea—Irinotecan—pancreatic cancer	0.000109	0.000586	CcSEcCtD
Hydroxyurea—Nervous system disorder—Docetaxel—pancreatic cancer	0.000108	0.00058	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000108	0.000579	CcSEcCtD
Hydroxyurea—Drowsiness—Doxorubicin—pancreatic cancer	0.000108	0.000579	CcSEcCtD
Hydroxyurea—Infestation—Doxorubicin—pancreatic cancer	0.000108	0.000579	CcSEcCtD
Hydroxyurea—Infestation NOS—Doxorubicin—pancreatic cancer	0.000108	0.000579	CcSEcCtD
Hydroxyurea—Skin disorder—Docetaxel—pancreatic cancer	0.000107	0.000575	CcSEcCtD
Hydroxyurea—Diarrhoea—Gemcitabine—pancreatic cancer	0.000106	0.000571	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000106	0.000568	CcSEcCtD
Hydroxyurea—Dizziness—Irinotecan—pancreatic cancer	0.000105	0.000566	CcSEcCtD
Hydroxyurea—Haemoglobin—Epirubicin—pancreatic cancer	0.000105	0.000565	CcSEcCtD
Hydroxyurea—Stomatitis—Doxorubicin—pancreatic cancer	0.000105	0.000565	CcSEcCtD
Hydroxyurea—Anorexia—Docetaxel—pancreatic cancer	0.000105	0.000564	CcSEcCtD
Hydroxyurea—Haemorrhage—Epirubicin—pancreatic cancer	0.000104	0.000562	CcSEcCtD
Hydroxyurea—Diarrhoea—Fluorouracil—pancreatic cancer	0.000104	0.000561	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000102	0.000548	CcSEcCtD
Hydroxyurea—Vomiting—Irinotecan—pancreatic cancer	0.000101	0.000544	CcSEcCtD
Hydroxyurea—Dizziness—Fluorouracil—pancreatic cancer	0.000101	0.000542	CcSEcCtD
Hydroxyurea—Rash—Irinotecan—pancreatic cancer	0.0001	0.00054	CcSEcCtD
Hydroxyurea—Dermatitis—Irinotecan—pancreatic cancer	0.0001	0.000539	CcSEcCtD
Hydroxyurea—Headache—Irinotecan—pancreatic cancer	9.97e-05	0.000536	CcSEcCtD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	9.95e-05	0.0015	CbGpPWpGaD
Hydroxyurea—Vomiting—Gemcitabine—pancreatic cancer	9.86e-05	0.00053	CcSEcCtD
Hydroxyurea—Dyspnoea—Docetaxel—pancreatic cancer	9.81e-05	0.000528	CcSEcCtD
Hydroxyurea—Somnolence—Docetaxel—pancreatic cancer	9.78e-05	0.000526	CcSEcCtD
Hydroxyurea—Rash—Gemcitabine—pancreatic cancer	9.78e-05	0.000526	CcSEcCtD
Hydroxyurea—Dermatitis—Gemcitabine—pancreatic cancer	9.77e-05	0.000525	CcSEcCtD
Hydroxyurea—Haemoglobin—Doxorubicin—pancreatic cancer	9.71e-05	0.000523	CcSEcCtD
Hydroxyurea—Headache—Gemcitabine—pancreatic cancer	9.71e-05	0.000522	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GLP1R—pancreatic cancer	9.71e-05	0.00146	CbGpPWpGaD
Hydroxyurea—Vomiting—Fluorouracil—pancreatic cancer	9.69e-05	0.000521	CcSEcCtD
Hydroxyurea—Dyspepsia—Docetaxel—pancreatic cancer	9.68e-05	0.000521	CcSEcCtD
Hydroxyurea—Haemorrhage—Doxorubicin—pancreatic cancer	9.66e-05	0.00052	CcSEcCtD
Hydroxyurea—Rash—Fluorouracil—pancreatic cancer	9.61e-05	0.000517	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—RB1—pancreatic cancer	9.61e-05	0.00145	CbGpPWpGaD
Hydroxyurea—Dermatitis—Fluorouracil—pancreatic cancer	9.6e-05	0.000517	CcSEcCtD
Hydroxyurea—Decreased appetite—Docetaxel—pancreatic cancer	9.56e-05	0.000514	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—DPYD—pancreatic cancer	9.55e-05	0.00144	CbGpPWpGaD
Hydroxyurea—Headache—Fluorouracil—pancreatic cancer	9.55e-05	0.000514	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Docetaxel—pancreatic cancer	9.5e-05	0.000511	CcSEcCtD
Hydroxyurea—Fatigue—Docetaxel—pancreatic cancer	9.49e-05	0.00051	CcSEcCtD
Hydroxyurea—Angiopathy—Epirubicin—pancreatic cancer	9.48e-05	0.00051	CcSEcCtD
Hydroxyurea—Nausea—Irinotecan—pancreatic cancer	9.45e-05	0.000509	CcSEcCtD
Hydroxyurea—Pain—Docetaxel—pancreatic cancer	9.41e-05	0.000506	CcSEcCtD
Hydroxyurea—Constipation—Docetaxel—pancreatic cancer	9.41e-05	0.000506	CcSEcCtD
Hydroxyurea—Chills—Epirubicin—pancreatic cancer	9.37e-05	0.000504	CcSEcCtD
Hydroxyurea—Alopecia—Epirubicin—pancreatic cancer	9.23e-05	0.000497	CcSEcCtD
Hydroxyurea—Nausea—Gemcitabine—pancreatic cancer	9.21e-05	0.000495	CcSEcCtD
Hydroxyurea—Erythema—Epirubicin—pancreatic cancer	9.09e-05	0.000489	CcSEcCtD
Hydroxyurea—Feeling abnormal—Docetaxel—pancreatic cancer	9.07e-05	0.000488	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—SLC2A2—pancreatic cancer	9.06e-05	0.00137	CbGpPWpGaD
Hydroxyurea—Nausea—Fluorouracil—pancreatic cancer	9.05e-05	0.000487	CcSEcCtD
Hydroxyurea—Angiopathy—Doxorubicin—pancreatic cancer	8.77e-05	0.000472	CcSEcCtD
Hydroxyurea—Body temperature increased—Docetaxel—pancreatic cancer	8.7e-05	0.000468	CcSEcCtD
Hydroxyurea—Chills—Doxorubicin—pancreatic cancer	8.67e-05	0.000466	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—RB1—pancreatic cancer	8.59e-05	0.00129	CbGpPWpGaD
Hydroxyurea—Alopecia—Doxorubicin—pancreatic cancer	8.54e-05	0.000459	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—CD44—pancreatic cancer	8.52e-05	0.00128	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	8.44e-05	0.00127	CbGpPWpGaD
Hydroxyurea—Ill-defined disorder—Epirubicin—pancreatic cancer	8.44e-05	0.000454	CcSEcCtD
Hydroxyurea—Erythema—Doxorubicin—pancreatic cancer	8.41e-05	0.000453	CcSEcCtD
Hydroxyurea—Anaemia—Epirubicin—pancreatic cancer	8.4e-05	0.000452	CcSEcCtD
Hydroxyurea—Malaise—Epirubicin—pancreatic cancer	8.2e-05	0.000441	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—GCG—pancreatic cancer	8.17e-05	0.00123	CbGpPWpGaD
Hydroxyurea—Leukopenia—Epirubicin—pancreatic cancer	8.14e-05	0.000438	CcSEcCtD
Hydroxyurea—Hypersensitivity—Docetaxel—pancreatic cancer	8.11e-05	0.000436	CcSEcCtD
Hydroxyurea—Asthenia—Docetaxel—pancreatic cancer	7.89e-05	0.000425	CcSEcCtD
Hydroxyurea—Convulsion—Epirubicin—pancreatic cancer	7.88e-05	0.000424	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.81e-05	0.00042	CcSEcCtD
Hydroxyurea—Anaemia—Doxorubicin—pancreatic cancer	7.78e-05	0.000418	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	7.69e-05	0.000414	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—STK11—pancreatic cancer	7.68e-05	0.00116	CbGpPWpGaD
Hydroxyurea—Discomfort—Epirubicin—pancreatic cancer	7.65e-05	0.000411	CcSEcCtD
Hydroxyurea—Malaise—Doxorubicin—pancreatic cancer	7.59e-05	0.000408	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CDKN2A—pancreatic cancer	7.55e-05	0.00114	CbGpPWpGaD
Hydroxyurea—Leukopenia—Doxorubicin—pancreatic cancer	7.53e-05	0.000405	CcSEcCtD
Hydroxyurea—Diarrhoea—Docetaxel—pancreatic cancer	7.53e-05	0.000405	CcSEcCtD
Hydroxyurea—Oedema—Epirubicin—pancreatic cancer	7.42e-05	0.000399	CcSEcCtD
Hydroxyurea—Infection—Epirubicin—pancreatic cancer	7.37e-05	0.000397	CcSEcCtD
Hydroxyurea—Convulsion—Doxorubicin—pancreatic cancer	7.29e-05	0.000392	CcSEcCtD
Hydroxyurea—Nervous system disorder—Epirubicin—pancreatic cancer	7.28e-05	0.000391	CcSEcCtD
Hydroxyurea—Dizziness—Docetaxel—pancreatic cancer	7.28e-05	0.000391	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Epirubicin—pancreatic cancer	7.27e-05	0.000391	CcSEcCtD
Hydroxyurea—Skin disorder—Epirubicin—pancreatic cancer	7.21e-05	0.000388	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—CCND1—pancreatic cancer	7.13e-05	0.00107	CbGpPWpGaD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.11e-05	0.000383	CcSEcCtD
Hydroxyurea—Discomfort—Doxorubicin—pancreatic cancer	7.08e-05	0.000381	CcSEcCtD
Hydroxyurea—Anorexia—Epirubicin—pancreatic cancer	7.07e-05	0.000381	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—CD44—pancreatic cancer	7.02e-05	0.00106	CbGpPWpGaD
Hydroxyurea—Vomiting—Docetaxel—pancreatic cancer	7e-05	0.000376	CcSEcCtD
Hydroxyurea—Rash—Docetaxel—pancreatic cancer	6.94e-05	0.000373	CcSEcCtD
Hydroxyurea—Dermatitis—Docetaxel—pancreatic cancer	6.93e-05	0.000373	CcSEcCtD
Hydroxyurea—Headache—Docetaxel—pancreatic cancer	6.89e-05	0.000371	CcSEcCtD
Hydroxyurea—Oedema—Doxorubicin—pancreatic cancer	6.87e-05	0.000369	CcSEcCtD
Hydroxyurea—Infection—Doxorubicin—pancreatic cancer	6.82e-05	0.000367	CcSEcCtD
Hydroxyurea—Nervous system disorder—Doxorubicin—pancreatic cancer	6.73e-05	0.000362	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—GCG—pancreatic cancer	6.73e-05	0.00101	CbGpPWpGaD
Hydroxyurea—Thrombocytopenia—Doxorubicin—pancreatic cancer	6.72e-05	0.000362	CcSEcCtD
Hydroxyurea—Skin disorder—Doxorubicin—pancreatic cancer	6.67e-05	0.000359	CcSEcCtD
Hydroxyurea—Dyspnoea—Epirubicin—pancreatic cancer	6.62e-05	0.000356	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—TYMS—pancreatic cancer	6.61e-05	0.000996	CbGpPWpGaD
Hydroxyurea—Somnolence—Epirubicin—pancreatic cancer	6.6e-05	0.000355	CcSEcCtD
Hydroxyurea—Anorexia—Doxorubicin—pancreatic cancer	6.55e-05	0.000352	CcSEcCtD
Hydroxyurea—Nausea—Docetaxel—pancreatic cancer	6.54e-05	0.000352	CcSEcCtD
Hydroxyurea—Dyspepsia—Epirubicin—pancreatic cancer	6.53e-05	0.000351	CcSEcCtD
Hydroxyurea—Decreased appetite—Epirubicin—pancreatic cancer	6.45e-05	0.000347	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.41e-05	0.000345	CcSEcCtD
Hydroxyurea—Fatigue—Epirubicin—pancreatic cancer	6.4e-05	0.000344	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—CCND1—pancreatic cancer	6.38e-05	0.000961	CbGpPWpGaD
Hydroxyurea—Pain—Epirubicin—pancreatic cancer	6.35e-05	0.000341	CcSEcCtD
Hydroxyurea—Constipation—Epirubicin—pancreatic cancer	6.35e-05	0.000341	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—STK11—pancreatic cancer	6.33e-05	0.000953	CbGpPWpGaD
Hydroxyurea—Dyspnoea—Doxorubicin—pancreatic cancer	6.12e-05	0.000329	CcSEcCtD
Hydroxyurea—Feeling abnormal—Epirubicin—pancreatic cancer	6.12e-05	0.000329	CcSEcCtD
Hydroxyurea—Somnolence—Doxorubicin—pancreatic cancer	6.1e-05	0.000328	CcSEcCtD
Hydroxyurea—Dyspepsia—Doxorubicin—pancreatic cancer	6.04e-05	0.000325	CcSEcCtD
Hydroxyurea—Decreased appetite—Doxorubicin—pancreatic cancer	5.97e-05	0.000321	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.93e-05	0.000319	CcSEcCtD
Hydroxyurea—Fatigue—Doxorubicin—pancreatic cancer	5.92e-05	0.000318	CcSEcCtD
Hydroxyurea—Constipation—Doxorubicin—pancreatic cancer	5.87e-05	0.000316	CcSEcCtD
Hydroxyurea—Pain—Doxorubicin—pancreatic cancer	5.87e-05	0.000316	CcSEcCtD
Hydroxyurea—Body temperature increased—Epirubicin—pancreatic cancer	5.87e-05	0.000316	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.72e-05	0.000862	CbGpPWpGaD
Hydroxyurea—Feeling abnormal—Doxorubicin—pancreatic cancer	5.66e-05	0.000304	CcSEcCtD
Hydroxyurea—Hypersensitivity—Epirubicin—pancreatic cancer	5.47e-05	0.000294	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—TYMS—pancreatic cancer	5.44e-05	0.00082	CbGpPWpGaD
Hydroxyurea—Body temperature increased—Doxorubicin—pancreatic cancer	5.43e-05	0.000292	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—APOE—pancreatic cancer	5.37e-05	0.00081	CbGpPWpGaD
Hydroxyurea—Asthenia—Epirubicin—pancreatic cancer	5.32e-05	0.000286	CcSEcCtD
Hydroxyurea—RRM2—Cell Cycle—MYC—pancreatic cancer	5.12e-05	0.000771	CbGpPWpGaD
Hydroxyurea—Diarrhoea—Epirubicin—pancreatic cancer	5.08e-05	0.000273	CcSEcCtD
Hydroxyurea—Hypersensitivity—Doxorubicin—pancreatic cancer	5.06e-05	0.000272	CcSEcCtD
Hydroxyurea—Asthenia—Doxorubicin—pancreatic cancer	4.93e-05	0.000265	CcSEcCtD
Hydroxyurea—Dizziness—Epirubicin—pancreatic cancer	4.91e-05	0.000264	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CG—pancreatic cancer	4.85e-05	0.000731	CbGpPWpGaD
Hydroxyurea—Vomiting—Epirubicin—pancreatic cancer	4.72e-05	0.000254	CcSEcCtD
Hydroxyurea—Diarrhoea—Doxorubicin—pancreatic cancer	4.7e-05	0.000253	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PPARG—pancreatic cancer	4.68e-05	0.000706	CbGpPWpGaD
Hydroxyurea—Rash—Epirubicin—pancreatic cancer	4.68e-05	0.000252	CcSEcCtD
Hydroxyurea—Dermatitis—Epirubicin—pancreatic cancer	4.67e-05	0.000251	CcSEcCtD
Hydroxyurea—Headache—Epirubicin—pancreatic cancer	4.65e-05	0.00025	CcSEcCtD
Hydroxyurea—Dizziness—Doxorubicin—pancreatic cancer	4.54e-05	0.000244	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—APOE—pancreatic cancer	4.43e-05	0.000667	CbGpPWpGaD
Hydroxyurea—Nausea—Epirubicin—pancreatic cancer	4.41e-05	0.000237	CcSEcCtD
Hydroxyurea—Vomiting—Doxorubicin—pancreatic cancer	4.37e-05	0.000235	CcSEcCtD
Hydroxyurea—Rash—Doxorubicin—pancreatic cancer	4.33e-05	0.000233	CcSEcCtD
Hydroxyurea—Dermatitis—Doxorubicin—pancreatic cancer	4.33e-05	0.000233	CcSEcCtD
Hydroxyurea—Headache—Doxorubicin—pancreatic cancer	4.3e-05	0.000231	CcSEcCtD
Hydroxyurea—RRM1—Metabolism—PIK3CD—pancreatic cancer	4.26e-05	0.000643	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—pancreatic cancer	4.2e-05	0.000633	CbGpPWpGaD
Hydroxyurea—Nausea—Doxorubicin—pancreatic cancer	4.08e-05	0.000219	CcSEcCtD
Hydroxyurea—RRM2—Metabolism—PIK3CG—pancreatic cancer	3.99e-05	0.000602	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARG—pancreatic cancer	3.86e-05	0.000581	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CB—pancreatic cancer	3.72e-05	0.00056	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTGS2—pancreatic cancer	3.68e-05	0.000555	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CD—pancreatic cancer	3.51e-05	0.000529	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PTEN—pancreatic cancer	3.21e-05	0.000484	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CB—pancreatic cancer	3.06e-05	0.000461	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTGS2—pancreatic cancer	3.03e-05	0.000457	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.03e-05	0.000456	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PTEN—pancreatic cancer	2.64e-05	0.000399	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.63e-05	0.000396	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.29e-05	0.000346	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PIK3CA—pancreatic cancer	2.27e-05	0.000341	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PIK3CA—pancreatic cancer	1.87e-05	0.000281	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—AKT1—pancreatic cancer	1.85e-05	0.000279	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.85e-05	0.000279	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.82e-05	0.000274	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.73e-05	0.00026	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—AKT1—pancreatic cancer	1.52e-05	0.00023	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CD44—pancreatic cancer	1.34e-05	0.000202	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—GCG—pancreatic cancer	1.28e-05	0.000193	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—STK11—pancreatic cancer	1.21e-05	0.000182	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.04e-05	0.000156	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—APOE—pancreatic cancer	8.43e-06	0.000127	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	7.61e-06	0.000115	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.35e-06	0.000111	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	6.69e-06	0.000101	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	5.83e-06	8.79e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTGS2—pancreatic cancer	5.78e-06	8.71e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.04e-06	7.59e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.56e-06	5.36e-05	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.9e-06	4.38e-05	CbGpPWpGaD
